Li Y - Search Results

1

A series of beta-carboline derivatives inhibit the kinase activity of PLKs.

Han X, Zhang J, Guo L, Cao R, Li Y, Li N, Ma Q, Wu J, Wang Y, Si S. Han X, et al. Among authors: li y, li n. PLoS One. 2012;7(10):e46546. doi: 10.1371/journal.pone.0046546. Epub 2012 Oct 3. PLoS One. 2012. PMID: 23056340 Free PMC article.

2

A small molecule, MTBT, prevents cancer cell growth by activating p38 MAPK.

Li Y, Zhang X, Zhang J, Li Y, Liu W, Wang Z, Wang Y, Si S. Li Y, et al. Anticancer Drugs. 2014 Apr;25(4):423-32. doi: 10.1097/CAD.0000000000000074. Anticancer Drugs. 2014. PMID: 24441745 Free PMC article.

3

Identification of antituberculosis agents that target ribosomal protein interactions using a yeast two-hybrid system.

Lin Y, Li Y, Zhu Y, Zhang J, Li Y, Liu X, Jiang W, Yu S, You XF, Xiao C, Hong B, Wang Y, Jiang JD, Si S. Lin Y, et al. Among authors: li y. Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17412-7. doi: 10.1073/pnas.1110271109. Epub 2012 Oct 8. Proc Natl Acad Sci U S A. 2012. PMID: 23045703 Free PMC article.

4

Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library.

Li N, Xu Y, Feng T, Liu C, Li Y, Wang X, Si S. Li N, et al. Among authors: li y. J Biomol Screen. 2014 Apr;19(4):566-74. doi: 10.1177/1087057113516004. Epub 2013 Dec 13. J Biomol Screen. 2014. PMID: 24334278

5

Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.

Li N, Wang X, Zhang J, Liu C, Li Y, Feng T, Xu Y, Si S. Li N, et al. Among authors: li y. Biochem Pharmacol. 2014 Dec 1;92(3):438-47. doi: 10.1016/j.bcp.2014.09.017. Epub 2014 Oct 17. Biochem Pharmacol. 2014. PMID: 25450668

6

Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis.

Liu C, Feng T, Zhu N, Liu P, Han X, Chen M, Wang X, Li N, Li Y, Xu Y, Si S. Liu C, et al. Among authors: li y, li n. Sci Rep. 2015 Apr 1;5:9530. doi: 10.1038/srep09530. Sci Rep. 2015. PMID: 25827822 Free PMC article.

7

Optimization of Rutaecarpine as ABCA1 Up-Regulator for Treating Atherosclerosis.

Li Y, Feng T, Liu P, Liu C, Wang X, Li D, Li N, Chen M, Xu Y, Si S. Li Y, et al. Among authors: li d, li n. ACS Med Chem Lett. 2014 Jun 24;5(8):884-8. doi: 10.1021/ml500131a. eCollection 2014 Aug 14. ACS Med Chem Lett. 2014. PMID: 25147608 Free PMC article.

8

Identification of Novel Compounds Enhancing SR-BI mRNA Stability through High-Throughput Screening.

Jia XJ, Du Y, Jiang HJ, Li YZ, Xu YN, Si SY, Wang L, Hong B. Jia XJ, et al. Among authors: li yz. SLAS Discov. 2020 Apr;25(4):397-408. doi: 10.1177/2472555219894543. Epub 2019 Dec 20. SLAS Discov. 2020. PMID: 31858876 Free article.

9

Rutaecarpine suppresses atherosclerosis in ApoE-/- mice through upregulating ABCA1 and SR-BI within RCT.

Xu Y, Liu Q, Xu Y, Liu C, Wang X, He X, Zhu N, Liu J, Wu Y, Li Y, Li N, Feng T, Lai F, Zhang M, Hong B, Jiang JD, Si S. Xu Y, et al. Among authors: li y, li n. J Lipid Res. 2014 Aug;55(8):1634-47. doi: 10.1194/jlr.M044198. Epub 2014 Jun 7. J Lipid Res. 2014. PMID: 24908654 Free PMC article.

10

Identification of trichostatin derivatives from Streptomyces sp. CPCC 203909.

Chen M, Wu Y, He Y, Xu Y, Li Y, Li D, Feng T, Yu L, Hong B, Jiang W, Si S. Chen M, et al. Among authors: li d, li y. Bioorg Med Chem Lett. 2015 Feb 1;25(3):562-5. doi: 10.1016/j.bmcl.2014.12.030. Epub 2014 Dec 19. Bioorg Med Chem Lett. 2015. PMID: 25556102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235,560 results

Search Page

Filters